Cidara Corp (CDTX) Amount of Cash per Share

Cash per share illustrates the financial resilience of Cidara Therapeutics (CDTX), while 13.54 represents the current level of this metric amidst clinical trial volatility. The business relies on the Cloudbreak platform, which ensures high value for hospital drugs. The company's innovations are based on developing immunotherapies to combat severe infections by enhancing patients' natural immunity.
Comprehensive metric breakdowns and analytics for Cidara Therapeutics (CDTX)

When assessing the margin of safety for Cidara Therapeutics (CDTX), it is essential to understand that this metric measures the volume of available liquidity per common share, determining the actual value of the "cash cushion" for the shareholder. The trend of highly liquid assets per share confirms the company's ability to seamlessly fund the procurement of biocomponents through diversified international supply channels, minimizing the risk of halting critical research.